Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05831787 · OUTCOME

EHR COVID 19 Related Outcomes on Study

COVID19 OutcomeS in Myeloma and the Impact of VaCcines · Source last updated 2026-05-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
During 6 month study period

What was measured

Hospitalization related to COVID-19 was ascertained through electronic health record (EHR) data obtained with participant permission. COVID-19-related outcomes included COVID-19 infection and associated clinical events (e.g., hospitalization), as documented in the EHR.

Analysis population: Among the enrolled participants, 79 consented to share their electronic health record (EHR) data. Participation in EHR data sharing was optional and not a requirement of the study.

Groups in this outcome

Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease

Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease79

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease12Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        12
denoms
  1. counts
    1. group Id
      OG000
      value
      79
    units
    Participants
description
Hospitalization related to COVID-19 was ascertained through electronic health record (EHR) data obtained with participant permission. COVID-19-related outcomes included COVID-19 infection and associated clinical events (e.g., hospitalization), as documented in the EHR.
groups
  1. description
    Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.
    id
    OG000
    title
    Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease
param Type
COUNT_OF_PARTICIPANTS
population Description
Among the enrolled participants, 79 consented to share their electronic health record (EHR) data. Participation in EHR data sharing was optional and not a requirement of the study.
reporting Status
POSTED
time Frame
During 6 month study period
title
EHR COVID 19 Related Outcomes on Study
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice